Investors scrap for Teva Pharmaceutical bonds

NEW YORK, July 22 (IFR) - Teva Pharmaceutical raised more

than US$20bn across three currencies this week via an

acquisition-driven bond that took advantage of pent-up demand

for corporate paper in a yield-starved market.

Read more